Mitsubishi won't slash prices to remain a top-five brand in Australia
'While we have acknowledged a top-five volume target in the past, we aren't targeting a specific ranking or number,' Mitsubishi Motors Australia Limited CEO Shaun Westcott told CarExpert as part of an interview for our Expert Insights series.
'Our focus remains on delivering quality vehicles that consumers want, and supporting them throughout their ownership experience, while remaining profitable.'
Last year, Mitsubishi delivered 74,547 vehicles in Australia, making it the fifth best-selling brand on the market. It was up one spot and over 11,000 sales compared with its 2023 tally, though down slightly on its fourth-place position in 2022 when it delivered close to 77,000 vehicles.
Hundreds of new car deals are available through CarExpert right now. Get the experts on your side and score a great deal.
Browse now
.
Mitsubishi sales have ebbed and flowed somewhat over the years. It reached a height of 84,123 deliveries in 1998, but annual deliveries wouldn't exceed 80,000 units again until 2017. It managed this feat in 2018 and 2019 as well, in the dying days of the popular Lancer.
While Mitsubishi vehicles like the outgoing ASX have often undercut rivals from Japan and Europe, a raft of Chinese brands have entered the Australian market with sharply priced vehicles of their own.
The ASX opens at $24,290 before on-road costs, but the new
Chery Tiggo 4
opens at $23,990 drive-away.
Its Outlander, the second best-selling mid-size SUV in Australia, opens at $39,990 before on-roads, which sees it undercut by the
Chery Tiggo 8 Pro Max
,
MG HS
, and
GWM Haval H6
.
Many of these Chinese rivals have also offered significantly discounted pricing as part of runout or EOFY deals.
'In the current competitive landscape, heavily discounting and increasing incentives are a short-term race to the bottom,' said Mr Westcott.
'Mitsubishi is a volume player, but we have moved beyond being seen as 'cheap'; we are now known for creating value via well-equipped, capable and reliable vehicles that fit Australian customers.'
Likely to impact Mitsubishi's performance this year, however, is the loss of a few key vehicles.
A new Australian Design Rule (ADR) that came into effect on March 1, 2025, outlining specific performance requirements for autonomous emergency braking (AEB) systems, forced
Mitsubishi to discontinue
the
Eclipse Cross
,
Pajero Sport
, and the Japanese-built
ASX
.
The ASX nameplate isn't dead, however, with a replacement – a rebadged
Renault Captur
, built in Spain – due late on sale here in 2025.
Mitsubishi was also able to secure sufficient stock of discontinued vehicles, complied before March 1, to the point these vehicles remain on its local website as at the end of May.
The company still sold enough ASXs in April, for example, to make it the sixth best-selling vehicle in its segment.
The Pajero Sport also still managed to outsell sharply priced rivals from challenger brands like the
LDV D90
and
KGM Rexton
, even if it fell far short of the likes of the
Isuzu MU-X
.
A new-generation Pajero Sport is expected in 2026 following a commitment from the brand to remain in key vehicle segments in which the brand is already established.
Mitsubishi has confirmed it's in development, though whether it retains the Pajero Sport name is 'still to be decided'.
However, Mitsubishi says it's too early to confirm the
Renault Scenic E-Tech-based Eclipse Cross EV
set to be revealed in September, while a separate electric vehicle (EV) based on the
Nissan Leaf
and intended for North America is also uncertain to come here.
Instead, Mitsubishi has confirmed a new product in the shape of
an EV sourced from Taiwanese firm Foxtron
. It's due in Australia during the second half of 2026.
That will see Mitsubishi offer four to five nameplates in Australia by the end of 2026. Prior to March 1, Mitsubishi was importing vehicles into Australia across five nameplates.
Mitsubishi says between now and 2030 it will launch at least eight new and refreshed models in Australia.
'It has been well publicised, and I have to say sensationalised, that we reduced our model lineup at the start of 2025 due to a change in ADR requirements,' said Mr Westcott.
'This wasn't limited to Mitsubishi but also impacted other brands, who seem to have escaped some of the sensationalism.
'We did announce the replacement of the ASX simultaneously, but some media houses chose to ignore or downplay this in exchange for sensationalist headlines.
'The timing of this change restricted us to confirming only the ASX replacement at the time, but we also said other new models would be confirmed in due course which has subsequently happened, as promised.
'Our future lineup will include a balanced mix of petrol, diesel, PHEV, and EV models – all designed for the Australian lifestyle and backed by our 10/10 warranty and capped-price servicing.'
While the days of the Lancer, Magna and Pajero are long gone, Mitsubishi remains a high-volume brand in Australia thanks to the popularity of vehicles like the ASX, Outlander and Triton.
'From a Mitsubishi perspective, we have been selling vehicles in Australia for 45 years, and we intend to be here for the foreseeable future, and beyond,' said Mr Westcott.
'You can't buy history like that, or the affinity with the Australian market that it creates.
'Our Australian manufacturing legacy remains strong; we are part of the Australian fabric, particularly in South Australia. And that can create a strong emotional connection.'
Mr Westcott also noted Mitsubishi's network of over 200 dealers and extensive parts and aftersales support.
'We intend to remain a key player in the automotive segment in Australia for decades to come,' he added.
Our full Expert Insights interview with Shaun Westcott will be published on Saturday, May 31.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
16 minutes ago
- News.com.au
Criterion: Don't horse around with the Magnificent Seven dividend stocks this reporting season
• Dwindling yields from the dividend favourites mean investors should saddle up elsewhere • Led by the CBA, the 'Magnificent Seven' account for half of all dividends paid • Investors should avoid swapping growth thoroughbreds for high-yielding donkeys that won't last the distance On the cusp of the August profit reporting season, dividend yield chasers are mulling the top stocks likely to impress with their payouts. This year, they will need to look harder. Combined with elevated share valuations, subdued earnings are likely to diminish the appeal of the dividend faves. Historically, Australian investors have not looked too far in their quest for income. Of the ASX200 stocks, a mere seven account for half of all ASX dividends in 2024. For the record, they are the Big Four banks, BHP (ASX:BHP), Fortescue (ASX:FMG) and Woodside Energy Group (ASX:WDS). (This Magnificent Seven shouldn't be confused with the top US tech stocks which share the same nomenclature). The top dividend payer, the Commonwealth Bank (ASX:CBA) yields a sub-par 2.5% after its monstrous share run. The top 100 stocks account for 97% of the ASX200 index dividends. The average pre-tax yield has fallen to 3.2%. This compares to the historic run rate of 4.5% over the last ten years and 4-6% over the last five decades. "Airbag" protection The manager of Ausbil's active dividend income fund, Michael Price cautions that chasing dividends should not come at the cost of losing capital. With that in mind, the fund positions itself to capture the best dividends from events such as the upcoming reporting season, 'rather than passively buying and holding for a long time'. Atlas Funds Management's Hugh Dive counsels investors to pay close attention to capex requirements: companies needing to replace or upgrade assets won't be going on a dividend spree. Companies exposed to the US are likely to be preserving funds, given the 'what will Donald do next?' uncertainties. But Dive says dividend-paying stocks provide 'airbag' protection in a downturn: when yields become high enough, investors will jump back in. Don't bank on the banks Price says of the banks: 'I don't see much dividend growth coming over the next two or three years.' That said, the CBA remains the fund's biggest holding, as it's the next Big Four bank to pay a dividend (the others have a September 30 balance date). Ausbil's preferred Big Four bank is the runt of the litter, the Australia and New Zealand Banking Group (ASX:ANZ). But Price believes there's better value in Macquarie Group (ASX:MQG), which pays a lower div than the Big Four but makes up for this with its superior growth potential. 'It's always hard to know exactly where Macquarie will make its money, but it is a well-run business that benefits from volatility," he says. Insurers offer premium yields Price says domestic insurers such as Suncorp Group (ASX:SUN) and Insurance Australia (ASX:IAG) continue to post strong premium growth whilst managing claims pressure. The same applies to the listed health insurer Medibank Private (ASX:MPL) and NIB Holdings (ASX:NHF). Ausbil has also got back on the old dividend warhorse Telstra (ASX:TLS), given more rational competition in the mobile sector. Price cites the 'quality end' of discretionary retailing: stocks such as JB HiFi (ASX:JBH), or the nation's biggest car yard, AP Eagers. But for the first time in years, Ausbil won't be riding into the reporting season with dividend faithfuls Woolworths (ASX:WOW) and Coles Group (ASX:COL). These grocers have been stabled because of competitive pressure (read Aldi), regulatory scrutiny over profit gouging claims, management upheaval and elevated capital spending. Sonic booms on pathology demand Atlas's Dive nominates Sonic Healthcare (ASX:SHL), the world's biggest pathology provider trading on an approximate 4.5% yield. Sonic benefits from an older population and one of the few companies genuinely likely to benefit from AI. Unlike other health companies, pathology providers don't have to spend a poultice on R&D. At the smaller end, Plato Investment Management's Peter Gardner likes Ventia Services (ASX:VNT), which manages infrastructure and public assets. In December the competition regulator took the company to task over defence contracts, but the company seems to have weathered the storm. Ventia yields round 5%. Digging up dividend delights Despite their earnings being subject to volatile commodity prices, the miners are cementing a new reputation for reliable dividends. Given the resilient iron price, the payouts from BHP, Rio Tinto (ASX:RIO) and Fortescue could pleasantly surprise. Fortescue's dividend capacity is bolstered by the $1 billion-plus it won't spend on two ditched hydrogen projects. Price notes BHP paid an interim div one-third of that of two years ago. But the miner's final payout should equate to an attractive yield (of around 3.5%, before franking). So not all of the Magnificent Seven posse should be run out of town. For the gold miners, cash is flowing in like rivers of – er -gold. These days, they're more inclined to share the spoils with investors rather than chase the next El Dorado deposit.
AU Financial Review
37 minutes ago
- AU Financial Review
US reaches new trade deal with European Union
Global pharmaceutical giants, including Pfizer and Johnson & Johnson, are paying a tiny fraction of the billions of dollars they earn from drug sales in local taxes, at a time when they're lobbying US President Donald Trump to force an overhaul of Australia's Pharmaceutical Benefits Scheme. An analysis of earnings statements filed with the corporate regulator by five of the biggest US and European drugmakers shows the companies on average pay between 2 per cent and 4 per cent of their Australian sales in income tax. The numbers may make for uncomfortable reading for drug multinationals as they step up efforts to loosen the PBS' grip on the pricing of key medicines.
AU Financial Review
37 minutes ago
- AU Financial Review
ASX set for modest dip; US-China tipped to extend trade truce
Equity markets are staring down a high-stakes week, with earnings season, key inflation data and a US Federal Reserve meeting all on the radar – and plenty of scope for volatility as the ASX hovers near record highs. Local futures are pointing to a modest dip at Monday's open, even after Wall Street pushed higher again, with the S&P 500 notching its fifth consecutive record close. The Fed's interest rate decision, due Friday morning AEST, is likely to set the tone. While no change is expected, Chair Jerome Powell's remarks will be closely parsed for hints of a potential September cut — especially with economic data showing mixed signals. Non-farm payrolls and the central bank's preferred inflation measure are also due this week. Back home, Rio Tinto kicks off earnings season, while Wednesday's CPI report looms large. The Reserve Bank has flagged that any policy shift hinges on fresh inflation data, and a soft enough read could pave the way for a rate cut in August. Westpac expects headline inflation to come in at 0.9 per cent for the June quarter, or 2.3 per cent annually. The RBA's preferred trimmed mean is tipped to rise 0.7 per cent, to an annual pace of 2.7 per cent. With global equities on a tear and the ASX just 1 per cent shy of its own all-time high, some strategists are starting to question how far this rally can run. 'Bubble is a big word, but the notion that the sharemarket is egregiously overvalued is one that I am sympathetic to,' said GSFM's Stephen Miller. 'These things can go on for a while, but markets have a tendency to walk up the stairs and down the elevator shaft. But I think there comes a time, too, when people like me who have been defensive haven't got that right, yet.'
